Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients

Sudlow, Cathie; Mason, Gillian; Maurice, James; J. Wedderburn, Catherine; J. Hankey, Graeme

doi:10.1002/14651858.cd001246.pub2

Public

Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients

Published in Cochrane Database of Systematic Reviews • Oct 7, 2009

Authors:

Cathie Sudlow

Gillian Mason

James Maurice

Abstract

BACKGROUND: Aspirin is the most widely studied and prescribed antiplatelet agent for preventing serious vascular events, reducing the odds of such events among high vascular risk patients by about a quarter. Thienopyridine derivatives inhibit platelet activation by a different mechanism and so may b...

Subject

Thienopyridine

Medicine

Clopidogrel

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!